retatrutide phase 2 nejm 2023 obesity trial jastreboff π¨Breaking: Retatrutide's first 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No weight loss plateau β curve still descending Retatrutide Phase 3: 60% Achieved
Description
Timeline of Retatrutide Results: Week by Week The trial data shows weight loss beginning early and continuing throughout treatment
No representation is made that the information will remain accurate in the future, and no warranty of merchantability, fitness for a particular purpose, or non-infringement is provided in connection with the editorial content of this article
Heres an overview of what to expect
Regulation of ATP production by mitochondrial Ca(2+)
